ACEL vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACEL's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. While the company shows strong earnings growth and beats earnings estimates consistently, high leverage (Debt/Equity: 2.22) and weak insider sentiment counterbalance these positives. Valuation is mixed—trading below analyst target of $15.17 but above the conservative Graham Number of $5.93. The stock faces headwinds from recent price underperformance and insider selling, despite solid ROE and revenue momentum.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
ACEL vs TSLA: Head-to-Head Comparison
This page compares Accel Entertainment, Inc. (ACEL) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.